Actavis seeking FDA approval to market generic version of Gilead drug By: MarketWatch April 03, 2015 at 08:59 AM EDT Dublin-based company wants to sell a version of a pulmonary arterial hypertension treatment. Read More >> Related Stocks: Actavis Plc Gilead Sciences